View Post

Monkeypox Outbreak Turns More Severe

In COVID-19, Latest News by Precision Vaccinations

While the extent of the monkeypox outbreak appears to be slowing down, the U.S Centers for Disease Control and Prevention (CDC) disclosed today that people are experiencing severe manifestations of monkeypox virus (MPX) infection.
And the CDC confirmed there are medical countermeasures available to treat people infected with monkeypox.

View Post

U.S. CDC Confirms Sudan Ebolavirus Outbreak Risks

In COVID-19, Latest News by Precision Vaccinations

The U.S. Centers for Disease Control and Prevention (CDC) issued today Health Advisory CDCHAN-00477, focused on Uganda's current Sudan Ebolavirus disease (EVD) outbreak.
This is the fifth outbreak of EVD caused by the Sudan virus in Uganda since 2000. 
As of October 6, 2022, a total of 44 confirmed cases, ten confirmed deaths, and 20 probable deaths of EVD have been identified in Uganda since the outbreak began in September 2022.
The current Ebola outbreak has a 69% case fatality rate.

View Post

$4.8 Million Award Funds Betacoronavirus Vaccine Development

In COVID-19, Latest News by Precision Vaccinations

The Coalition for Epidemic Preparedness Innovations (CEPI) and Intravacc today announced the latest funding award to advance the development of vaccines that provide broad protection against SARS-CoV-2 (including its variants) and other Betacoronaviruses, which can be delivered intranasally.
Based in the Netherlands, the CEPI will provide seed funding of up to US$4.8 million to Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines.